Patients with emphysema, cystic fibrosis or other chronic lung disease are considered on an individual basis. Age is a flexible criterion. Patients over the age of 50 are scrutinized closely for evidence of disease in any other major organ systems and for the ability to tolerate the procedure and post-operative immunosuppressive therapy. Idiopathic pulmonary fibrosis, Alpha I Antitrypsin Deficiency, or emphysema. Cystic fibrosis, bronchictasis, Alpha I Antitrypsin Deficiency.
Age is a flexible criterion.
Patients over the age of 55 will be scrutinized closely for evidence of disease in other major organ systems and for the ability to tolerate the procedure and the post-operative immunosuppressive therapy. Pediatric patients are considered on an individual basis. Referring a Patient Patients are evaluated for the cardiothoracic transplant program after being referred by a physician. Initial telephone contact with the transplant coordinator initiates a referral protocol. The UMC team and the referring physician can then determine if immediate transfer to the hospital is required or if an outpatient evaluation should be scheduled.